Council for Innovation Promotion

Fact Check: The SHOP SAFE Act Would Improve Consumers’ Online Shopping Experience

The SHOP SAFE Act, which was introduced in the House of Representatives by Representatives Darrell Issa (R-CA), Jerry Nadler (D-NY), Ben Cline (R-VA), and Hank Johnson (D-GA) on June 11, is an important bill that would help protect consumers and businesses from harmful counterfeit products by making e-commerce platforms responsible for vetting products’ legitimacy. Despite […]

Fact Check: The SHOP SAFE Act Would Improve Consumers’ Online Shopping Experience Read More »

New Op-Ed from C4IP Co-Chairs David Kappos and Andrei Iancu: New Patent Guidance on AI Could Quash Innovation

C4IP Co-Chairs and former USPTO Directors Andrei Iancu and David Kappos just published a new opinion piece in the Wall Street Journal exploring how the ambiguity of the USPTO’s recent guidance on patenting AI-assisted inventions could inadvertently discourage inventors from making use of artificial intelligence tools. They highlight numerous ambiguities in the guidance — including

New Op-Ed from C4IP Co-Chairs David Kappos and Andrei Iancu: New Patent Guidance on AI Could Quash Innovation Read More »

Fact Check: Patents Are Not To Blame for High Drug Prices

Like inventors in every sector, drug developers rely on strong patent protections to create new and innovative medicines. However, because of the prices of many drugs, activists frequently blame patents and accuse companies of abusing the patent system with tactics such as “product hopping,” “evergreening,” and “patent thicketing.” This troubling trend continued during the Senate

Fact Check: Patents Are Not To Blame for High Drug Prices Read More »

Scroll to Top